About Inotiv Co
Inotiv Co is a publicly listed company based in Lafayette (United States) founded in 1974. Clinical development and regulatory services are provided by Inotiv. The company has 1,955 employees. Inotiv Co has completed 9 acquisitions, including Bolder BioPath, Envigo and Gateway Pharmacology. Inotiv Co offers products and services including Research Models, Toxicology Services, and Laboratory Diets. Its focus areas include Biopharma Outsourcing, Diversified and Biologics. Its legal entity is INOTIV, INC. Similar companies include Catalent, Surrozen and Curia; 1 of its 3 listed similar companies has raised funding.
Company details
Inotiv was founded in 1974 and is headquartered in Lafayette, United States. Nonclinical and clinical development services are delivered to pharmaceutical and biotechnology clients. Regulatory support, including safety assessments and compliance guidance, is handled across various therapeutic areas. Operations encompass toxicology studies, bioanalysis, and program management, primarily serving North American markets with facilities in multiple states.
- Headquarters Lafayette, United States
- Employees 1,955
- Stage Public
- SectorsHealthcare
- Website inotivco.com
- Social LinkedIn
- Legal Name Inotiv, Inc.
- Annual Revenue$266.1 M (USD)392as on Sep 30, 2024
- Net Profit-$108.89 M (USD)-4as on Sep 30, 2024
- EBITDA-$6.06 M (USD)-109as on Sep 30, 2024
- Employee Count1,955
- Investments & AcquisitionsBolder BioPath
& 8 more
Products & Services of Inotiv Co
Inotiv Co offers a comprehensive portfolio of products and services, including Research Models, Toxicology Services, and Laboratory Diets.
Provides models for therapeutic area studies in drug development
Conducts studies to evaluate chemical safety in research
Supplies specialized diets for consistent research outcomes
People of Inotiv Co
138 people are tracked at Inotiv Co (70 in leadership, 6 in board & advisors, 62 in team); the tracked headcount is 1,955.
| Name | Role | Group |
|---|---|---|
Johnathan Furr | Director Developmental And Reproductive Toxicology | Leadership |
Robert Leasure Jr. | CEO | Leadership |
Beth A. Taylor | SVP, Finance & CFO | Leadership |
Lizanne Muller | Group President, RMS | Leadership |
Mike Garrett | Chief Commercial Officer | Leadership |
Jaymie Voorhees | Study Director II | Leadership |
Chris Null | Study Director | Leadership |
Glenn Washer | Group President, Safety Assessment | Leadership |
Greg Beattie | COO, DSA | Leadership |
John Sagartz | Chief Strategy Officer | Leadership |
Brennan Freeman | Vice President - Finance & Corporate Controller | Leadership |
James Norman | Vice President Of Business Development - Discovery & Translational Sciences | Leadership |
Diane Brecha | Senior Director Business Development | Leadership |
Bryan Lee | US Government Sales Director | Leadership |
Jason Werner | Director, Quality Management Systems | Leadership |
Travis Rothrock | Director, Portfolio Marketing | Leadership |
Cole Mietzner | Vice President - Information Security And Infrastructure | Leadership |
Seth H. | Associate Director Business Development | Leadership |
Nicole McDaniel | Director, Corporate Accounting & External Reporting | Leadership |
Chris Coffman | Senior Director Financial Planning Analysis | Leadership |
118 more people are available in the full profile.
Complete people profiles for Inotiv Co
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Inotiv Co
Inotiv Co is a publicly listed company on the NASDAQ with ticker symbol NOTV in USA, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date28 Nov 1997
- Listed onNASDAQ: NOTV
- Listed entityInotiv, Inc.
- Exchange sectorCommercial services
Investments & Acquisitions by Inotiv Co
Inotiv Co has strategically engaged in corporate development activities, having acquired 9 companies. Notable acquisitions include Bolder BioPath, Envigo and Gateway Pharmacology.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Provider of mass spectrometry based analytical solutions for drug safety and therapeutic development | protypia.com | Brentwood, United States | 2017 | Jul 2022 | •••• | |
Histopathology and medical device evaluation services are provided. | histion.com | Everett, United States | 2007 | Apr 2022 | •••• | |
Clinical research and regulatory services are provided by ILS. | ils-inc.com | Morrisville, United States | 1985 | Jan 2022 | $56M | |
Rabbit research and livestock services are provided globally. | rsirabbits.com | Mocksville, United States | 1986 | Jan 2022 | •••• | |
Drug discovery and development services are provided using research models. | envigo.com | Huntingdon, United Kingdom | 2015 | Nov 2021 | •••• | |
Provider of in vivo studies and also offering biochemical, biomarker, and histology services | platobiopharma.com | Westminster, United States | 2010 | Oct 2021 | $15M | |
Preclinical CRO offering rodent models for evaluating safety and efficacy of drugs, mainly in 6 major disease areas | gatewaypharmacology.com | Chesterfield, United States | 2012 | Aug 2021 | •••• | |
Bolder BioPath is engaged in contract pharmacology and pathology services. | bolderbiopath.com | Boulder, United States | 2003 | Apr 2021 | $47M | |
CRO offers histopathology and image analysis services | histotoxlabs.com | Boulder, United States | 2003 | Apr 2021 | $22M |
Complete acquisition details for Inotiv Co
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Inotiv Co
11 dated milestones of Inotiv Co across 48 years, from founding to its latest funding, stage changes and deals.
- Founded Inotiv Co is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires HistoTox.
- Acquisition Acquires Bolder BioPath.
- Acquisition Acquires Gateway Pharmacology.
- Acquisition Acquires Plato BioPharma.
- Acquisition Acquires Envigo.
- Acquisition Acquires Rsirabbits.com.
- Acquisition Acquires ILS (Integrated Laboratory Systems).
- Acquisition Acquires Histion.
- Acquisition Acquires Protypia.
Similar companies to Inotiv Co
Inotiv Co has 3 listed similar companies in our database, 1 of them funded. They include Catalent, Surrozen and Curia.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| catalent.com | 2007 | Somerset, United States | 9,390 | CDMO offering drug and biologics development services | ||
| surrozen.com | 2016 | San Francisco, United States | $133M | 80 | Selective Wnt agonists are developed for human tissue regeneration. | |
| curiaglobal.com | 1991 | Albany, United States | 1,918 | Drug research, development, testing, and consulting services are provided. |
Detailed similar companies of Inotiv Co
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Inotiv Co
The website of Inotiv Co (inotivco.com) receives about 1.3K visits a month.
- Monthly visits1.3K
▲ 42% vs previous month
Websites whose visitors overlap most with Inotiv Co. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| inotiv.com | 100% | 51.7K | #663,656 | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Inotiv Co (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Inotiv Co
Complete news archive for Inotiv Co
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Inotiv Co
Inotiv Co was founded in 1974.
Inotiv Co is headquartered in Lafayette, United States. It is registered at Lafayette, Louisiana, United States.
Inotiv Co has 1,955 employees.
Annual revenue of Inotiv Co is $266.1M as on Sep 30, 2024.
Inotiv was founded in 1974 and is headquartered in Lafayette, United States. Nonclinical and clinical development services are delivered to pharmaceutical and biotechnology clients. Regulatory support, including safety assessments and compliance guidance, is handled across various therapeutic areas. Operations encompass toxicology studies, bioanalysis, and program management, primarily serving North American markets with facilities in multiple states.
Inotiv Co offers Research Models, Toxicology Services, and Laboratory Diets.
Yes, Inotiv Co is publicly traded on NASDAQ under the ticker symbol NOTV.
Inotiv Co has made 9 acquisitions, including Bolder BioPath, Envigo, and Gateway Pharmacology.
Inotiv Co operates through Inotiv, Inc..